Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis from 2005-2016

Cesar Gentille Sanchez, MD, Joe Ensor, PhD, Akshjot Puri, MD, Jasleen K. Randhawa, MD, Shilpan S. Shah, MD, Sai Ravi Kiran Pingali, MD

Blood (2019) 134 (Supplement_1): 4022.

https://doi.org/10.1182/blood-2019-131991

Published: 2019

Journal Articles

Venous Thromboembolism in Lower Extremity Amputees: A Systematic Review of the Literature

Mohammed Abdullah Alsheef, MD, Sam Schulman, MD PhD FRCPC, Marco Donadini, MD, Abdul Rehman Z. Zaidi, MBBS

Blood (2019) 134 (Supplement_1): 4980.

https://doi.org/10.1182/blood-2019-130751

Published: 2019

Journal Articles

Maximum 24-Hour Platelet Count Fall Rate As a Predictor of HIT

Daniel S Lefler, MD, Adam Cuker, MD MS, Allyson M Pishko, MD

Blood (2019) 134 (Supplement_1): 1072.

https://doi.org/10.1182/blood-2019-131173

Published: 2019

Journal Articles

Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome — a Gimema CML WP Analysis

Blood (2017) 130 (Supplement 1): 1625.

https://doi.org/10.1182/blood.V130.Suppl_1.1625.1625

Published: 2017

Journal Articles

Immunoglobulin G in Normal Plasma Inhibits HIT Antibody-Mediated Platelet Activation: Implications for Therapeutic Plasma Exchange Treatment in HIT

Curtis Jones, BS, Shannon Pechauer, Brian R. Curtis, PhDMT(ASCP), Daniel W. Bougie, PhD, Richard H. Aster, MD, Anand Padmanabhan, MD PhD

Blood (2017) 130 (Supplement 1): 2402.

https://doi.org/10.1182/blood.V130.Suppl_1.2402.2402

Published: 2017

Journal Articles

Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke (CoBIS): Clinical Outcomes from a Phase 1 Safety Study

Joanne Kurtzberg, MD, Jesse D Troy, PhD, Ellen Bennett, PhD, Samir Belagaje, MD, Elizabeth J. Shpall, MD, Jonathan Wiese, MSN, RN, CNL, John Volpi, MD, Daniel Laskowitz, MD

Blood (2016) 128 (22): 2284.

https://doi.org/10.1182/blood.V128.22.2284.2284

Published: 2016

Journal Articles

Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria

Esra Turan Erkek, Esra Nazligul, Meliha Nalcaci, Melih Aktan, Mustafa Nuri Yenerel

Blood (2015) 126 (23): 4535.

https://doi.org/10.1182/blood.V126.23.4535.4535

Published: 2015

Journal Articles

Ferumoxytol-Contrasted MRI for Macrophage Imaging of Inflammation in Human Osteomyelitis, a Feasibility Study

Alexander Neuwelt, Marisa Rivera, Jonathan Orner, Thomas Byrd, Laurel Sillerud, Gary Mlady, Justin Baca, Jens Langsjoen

Blood (2015) 126 (23): 1016.

https://doi.org/10.1182/blood.V126.23.1016.1016

Published: 2015

Journal Articles

Implementation of a Heparin-Induced Thrombocytopenia Management Program Reduces the Cost of Diagnostic Testing and Pharmacologic Treatment in an Academic Medical Center

Caroline Dupre Vaughn, RN, Joseph Mazur, PharmD, Joyce Foster, MHS,MT(ASCP), John Lazarchick, MD, Alice Boylan, MD, Charles S Greenberg, MD

Blood (2014) 124 (21): 4848.

https://doi.org/10.1182/blood.V124.21.4848.4848

Published: 2014

Journal Articles

Correlation Of Heparin Confirmatory Test (HCT) With Optical Density (OD) and Serotonin Release Assay (SRA) In The Diagnosis Of Heparin Induced Thrombocytopenia (HIT)

Ravneet Thind, MD, Danielle Heidemann, MD, Sundara Raman, MD, Philip Kuriakose, MD

Blood (2013) 122 (21): 4754.

https://doi.org/10.1182/blood.V122.21.4754.4754

Published: 2013

Journal Articles

Increased Angiogenic Property Of Human Peripheral Blood Monocytes By ex Vivo Culture With c-Mpl Agonists In Hindlimb Ischemia Mouse Model

Junpei Sasajima, M.D, Ph.D, Toru Kawamoto, M.D, Ph.D, Yoshiaki Sugiyama, M.D, Ph.D, Yusuke Mizukami, Yasuyuki Iuchi, M.D, Ph.D, Toshifumi Ashida, M.D, Ph.D, Hiroki Tanabe, M.D, Ph.D, Yoshihiro Torimoto, MD, PhD, Yutaka Kohgo, MD, PhD

Blood (2013) 122 (21): 1062.

https://doi.org/10.1182/blood.V122.21.1062.1062

Published: 2013

Journal Articles

Paroxysmal Nocturnal Hemoglobinuria and Thrombosis Before and After Eculizumab

Cristina Muñoz-Linares, MD, Miguel Pastrana, MD, Emilio Ojeda, MD, PhD, Rafael Fores, MD, Martin Cabero, MD, Daniel Morillo, MD, Guiomar Bautista, MD, Belen Navarro, MD, Isabel Krsnik, MD, PhD, Santiago Gil, MD, PhD, Carmen Regidor, MD, PhD, Almudena de LaIglesia, MD, Jose Luis Bueno, MD, Jose A Garcia-Marco, MD, PhD, Jose Rafael Cabrera, MD, PhD

Blood (2013) 122 (21): 1242.

https://doi.org/10.1182/blood.V122.21.1242.1242

Published: 2013

Journal Articles

Treatment Of Infection-Associated Purpura Fulminans With Protein C Zymogen Is Associated With a High Survival Rate

Paul Knoebl, MD, Peter Schellongowski, MD, Thomas Staudinger, MD, Wolfgang R. Sperr, MD, Christian Scheibenpflug, MD

Blood (2013) 122 (21): 3606.

https://doi.org/10.1182/blood.V122.21.3606.3606

Published: 2013

Journal Articles

Cocaine-Levamisole Thrombovasculopathy: A Report From the Southern Network On Adverse Reactions (SONAR) Project

Charles Bennett, MD, PhD, MPP, Irene Dy, Peter Wiernik, MD, Jennie Buchanan, Richard Dart, Brian Edlin, Erin Gilbert, Priya Mahindra, Alanna Murday, BS, Zaina Parvez Qureshi, PhD, MPH

Blood (2012) 120 (21): 3403.

https://doi.org/10.1182/blood.V120.21.3403.3403

Published: 2012

Journal Articles

Elevated Risk of Peripheral Artery Occlusive Disease (PAOD) in Nilotinib Treated Chronic Phase Chronic Myeloid Leukemia (CML) Patients Assessed by Ankle-Brachial-Index (ABI) and Duplex Ultrasonography

Michaela Schwarz, MD, Theo D. Kim, MD, Tristan Mirault, Peggy Grille, Delphine Rea, MD, PhD, Ruhdja Lindhorst, Herve Dombret, MD, Ivo Buschmann, Wilhelm Haverkamp, Bernd Doerken, Philipp le Coutre, MD

Blood (2012) 120 (21): 914.

https://doi.org/10.1182/blood.V120.21.914.914

Published: 2012

Journal Articles

Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits

Steven D. Rhodes, Yongzheng He, M.D., Shi Chen, Hao Yang, Keshav M. Menon, Karl Staser, Ph.D., Xianlin Yang, Khalid S. Mohammad, M.D. Ph.D., Theresa Guise, M.D., Mingjiang Xu, M.D., Ph.D., Feng-chun Yang, M.D., Ph.D.

Blood (2012) 120 (21): 830.

https://doi.org/10.1182/blood.V120.21.830.830

Published: 2012

Journal Articles

Predicting Blood Loss and Transfusion Requirement in Patients Undergoing Surgery for Musculoskeletal Tumors

Philip A Thompson, MD, Deborah May, Peter Choong, Scott McArdle, Mary Gaskell, Gerard Powell, Danny Liew, Merrole Faye Cole-Sinclair

Blood (2012) 120 (21): 4384.

https://doi.org/10.1182/blood.V120.21.4384.4384

Published: 2012

Journal Articles

Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys

Husam S. Younis, Jeff Crosby, Jung-Im Huh, Hong Soo Lee, Soyub Rime, Brett Monia, Scott P. Henry

Blood (2012) 119 (10): 2401–2408.

https://doi.org/10.1182/blood-2011-10-387134

Published: 2012

Journal Articles

Nilotinib Exerts Direct Effects on Vascular Endothelial Cells and May Act As a Co-Trigger of Atherosclerosis in Patients with Ph+ CML

Emir Hadzijusufovic, DVM, Susanne Herndlhofer, Karl J. Aichberger, MD, PhD, Viviane Ghanim, M.D., Verena Suppan, BSc, Sabine Cerny-Reiterer, D.V.M., Wolfgang R Sperr, MD, Peter Valent, M.D.

Blood (2011) 118 (21): 2753.

https://doi.org/10.1182/blood.V118.21.2753.2753

Published: 2011

Journal Articles

ISIS-FXI Rx , a Potent Antisense Inhibitor of Factor XI, Suppresses FXI Activity and Elevates Aptt without Increased Risk of Bleeding in Cynomolgus Monkeys Following 13 Weeks of Treatment

Husam Younis, Jeff R. Crosby, PhD, Chenguang Zhao, Robert MacLeod, Ph.D., Brett P. Monia, PhD, Scott Henry

Blood (2011) 118 (21): 2255.

https://doi.org/10.1182/blood.V118.21.2255.2255

Published: 2011

NARROW

Primary Cutaneous Anaplastic Large-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis from 2005-2016

Venous Thromboembolism in Lower Extremity Amputees: A Systematic Review of the Literature

Maximum 24-Hour Platelet Count Fall Rate As a Predictor of HIT

Arterial Thrombotic Events in CML Patients Treated with First-Line Nilotinib: Incidence, Management and Impact on the Long Term Outcome — a Gimema CML WP Analysis

Immunoglobulin G in Normal Plasma Inhibits HIT Antibody-Mediated Platelet Activation: Implications for Therapeutic Plasma Exchange Treatment in HIT

Allogeneic Umbilical Cord Blood Infusion for Adults with Ischemic Stroke (CoBIS): Clinical Outcomes from a Phase 1 Safety Study

Circulating Endothelial Progenitor Cells and Their Relation to Thrombosis in Paroxysmal Nocturnal Hemoglobinuria

Ferumoxytol-Contrasted MRI for Macrophage Imaging of Inflammation in Human Osteomyelitis, a Feasibility Study

Implementation of a Heparin-Induced Thrombocytopenia Management Program Reduces the Cost of Diagnostic Testing and Pharmacologic Treatment in an Academic Medical Center

Correlation Of Heparin Confirmatory Test (HCT) With Optical Density (OD) and Serotonin Release Assay (SRA) In The Diagnosis Of Heparin Induced Thrombocytopenia (HIT)

Increased Angiogenic Property Of Human Peripheral Blood Monocytes By ex Vivo Culture With c-Mpl Agonists In Hindlimb Ischemia Mouse Model

Paroxysmal Nocturnal Hemoglobinuria and Thrombosis Before and After Eculizumab

Treatment Of Infection-Associated Purpura Fulminans With Protein C Zymogen Is Associated With a High Survival Rate

Cocaine-Levamisole Thrombovasculopathy: A Report From the Southern Network On Adverse Reactions (SONAR) Project

Elevated Risk of Peripheral Artery Occlusive Disease (PAOD) in Nilotinib Treated Chronic Phase Chronic Myeloid Leukemia (CML) Patients Assessed by Ankle-Brachial-Index (ABI) and Duplex Ultrasonography

Haploinsufficiency of Nf1 in Myeloid Lineages Contributes to Neurofibromatosis Type 1 Associated Skeletal Deficits

Predicting Blood Loss and Transfusion Requirement in Patients Undergoing Surgery for Musculoskeletal Tumors

Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys

Nilotinib Exerts Direct Effects on Vascular Endothelial Cells and May Act As a Co-Trigger of Atherosclerosis in Patients with Ph+ CML

ISIS-FXI Rx , a Potent Antisense Inhibitor of Factor XI, Suppresses FXI Activity and Elevates Aptt without Increased Risk of Bleeding in Cynomolgus Monkeys Following 13 Weeks of Treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only